CytomX Therapeutics (CTMX) Financials: Revenue & Earnings

CTMX price $2.37 +0.06 +2.38%

Ticker
CTMX
Price
$2.37
Change
+0.06 +2.38%
Market cap ?
$515.33M
P/E ?
-5.42
Forward P/E ?
67.57
Dividend yield ?
0.00%
Beta ?
2.20
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
46
Value
59
Quality
30
Growth
50

Stocklytics score rationale: value 59, quality 30, growth 50.

Financials

2016201720182019202020212022202320242025
1504300071623000595020005748900068427000373120005316300010121400013810300076201000

CytomX Therapeutics, Inc. is a United States-based biopharmaceutical company primarily focused on creating treatments for cancer. The company utilizes its proprietary Probody technology platform to engineer targeted antibody therapeutics for oncological applications. Its robust clinical pipeline includes several notable drug candidates. CX-2009, an antibody-drug conjugate (ADC) designed to target CD166, is currently…

Fair value

CTMX fair value $1.37. Price $2.37. Price is 73% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare CTMX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.09—10.38M
2026-08-06-0.09-0.081.42M12.39M
2026-05-07-0.10-0.1410.26M4.68M
2026-03-16-0.22-0.08661.00K7.33M
2025-11-06-0.09-0.055.96M7.33M
2025-08-07-0.00-0.0618.66M18.28M
2025-05-120.270.1250.92M35.42M
2025-03-060.22-0.2338.09M13.04M
2024-11-070.07-0.1733.43M13.53M
2024-08-08-0.08-0.1425.11M19.99M
2024-05-080.17-0.0841.46M21.43M
2024-03-110.01-0.0326.61M19.60M
2023-11-070.04-0.1926.38M20.41M
2023-08-08-0.02-0.2024.72M13.88M
2023-05-09-0.05-0.1123.50M19.59M
2023-03-27-0.43-0.2420.12M17.85M
2022-11-08-0.35-0.3111.15M18.15M
2022-08-04-0.37-0.3612.85M18.11M
2022-05-05-0.37-0.369.04M21.25M
2022-03-01-0.40-0.2819.73M19.57M
2021-11-04-0.35-0.3117.59M17.41M
2021-08-05-0.30-0.3216.29M16.29M
2021-05-06-0.26-0.3515.97M20.08M
2021-02-24-0.32-0.5016.37M22.27M
2020-11-05-0.32-0.4817.79M26.68M
2020-08-06-0.340.1616.61M7.82M
2020-05-070.26-0.4649.59M87.74M
2020-02-27-0.78-0.478.28M6.98M
2019-11-07-0.52-0.5110.71M10.51M
2019-08-07-0.64-0.579.01M8.03M
2019-05-09-0.31-0.5329.48M50.41M
2019-02-27-0.72-0.4811.47M7.65M
2018-11-06-0.53-0.4412.51M10.38M
2018-08-08-0.35-0.3221.34M19.51M
2018-05-09-0.40-0.4414.18M15.60M
2018-03-070.02-0.4327.07M415.12M
2017-11-07-0.28-0.1724.14M21.09M
2017-08-07-0.69-0.378.75M6.59M
2017-05-05-0.23-0.5111.65M25.84M
2017-03-02-0.39-0.436.27M6.92M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-03Carvajal AlejandraBuy450.00K$3.171.43M
2026-08-03Carvajal AlejandraBuy100.00K——
2026-08-03Carvajal AlejandraOther0——
2026-07-24Fuchs Charles S.Buy118.00K$3.24382.32K
2026-07-24Fuchs Charles S.Other0——
2026-06-17Su ZhenBuy59.00K$2.96174.64K
2026-06-17Young Matthew P.Buy59.00K$2.96174.64K
2026-06-17Mohindru ManiBuy59.00K$2.96174.64K
2026-06-17Meyers James RBuy59.00K$2.96174.64K
2026-06-17Gilbert Halley EBuy59.00K$2.96174.64K
2026-06-17Ashworth AlanBuy59.00K$2.96174.64K
2026-06-17Jones Elaine VBuy59.00K$2.96174.64K
2026-06-15Ogden ChristopherSell1.62K$3.054.95K
2026-03-17Chu Yu-WayeSell21.28K$6.42136.68K
2026-03-17McCarthy Sean A.Sell118.97K$6.42764.14K
2026-03-17BELVIN MARCIASell31.49K$6.42202.27K
2026-03-17Ogden ChristopherSell19.32K$6.42124.11K
2026-02-02Lester RachaelBuy50.00K$6.09304.50K
2026-02-02Lester RachaelBuy50.00K——
2026-02-02Lester RachaelBuy20.00K——
2026-02-02Chu Yu-WayeBuy300.00K$6.091.83M
2026-02-02Chu Yu-WayeBuy75.00K——
2026-02-02BELVIN MARCIABuy60.00K——
2026-02-02BELVIN MARCIABuy250.00K$6.091.52M
2026-02-02Ogden ChristopherBuy325.00K$6.091.98M
2026-02-02Ogden ChristopherBuy90.00K——
2026-02-02McCarthy Sean A.Buy210.00K——
2026-02-02McCarthy Sean A.Buy980.00K$6.095.97M
2025-11-06McCarthy Sean A.Buy101.79K$1.59161.85K
2025-11-06McCarthy Sean A.Sell101.79K$4.54461.91K
2025-11-06McCarthy Sean A.Sell101.79K$1.59161.85K
2025-11-06McCarthy Sean A.Sell101.79K$4.54461.91K
2025-10-20Lester RachaelBuy650.00K$3.742.43M
2025-10-20Lester RachaelOther0——
2025-09-26McCarthy Sean A.Buy570.00K$2.901.65M
2025-09-26McCarthy Sean A.Buy285.00K——
2025-09-26Chu Yu-WayeBuy87.50K$2.90253.75K
2025-09-26Chu Yu-WayeBuy43.75K——
2025-09-26Ogden ChristopherBuy78.25K$2.90226.93K
2025-09-26Ogden ChristopherBuy39.15K——
2025-09-26BELVIN MARCIABuy36.30K$2.90105.27K
2025-09-26BELVIN MARCIABuy18.15K——
2025-06-16Ogden ChristopherSell10.61K$2.6928.54K
2025-06-16BELVIN MARCIASell13.88K$2.6937.33K
2025-06-16McCarthy Sean A.Sell55.51K$2.69149.26K
2025-06-13Ogden ChristopherBuy37.50K——
2025-06-13Ogden ChristopherSell1.64K$2.954.84K
2025-06-13Ogden ChristopherSell37.50K——
2025-06-13BELVIN MARCIABuy37.50K——
2025-06-13BELVIN MARCIASell37.50K——
2025-06-13McCarthy Sean A.Buy150.00K——
2025-06-13McCarthy Sean A.Sell150.00K——
2025-06-11Su ZhenBuy38.00K$2.82107.16K
2025-06-11Young Matthew P.Buy38.00K$2.82107.16K
2025-06-11Mohindru ManiBuy38.00K$2.82107.16K
2025-06-11Meyers James RBuy38.00K$2.82107.16K
2025-06-11Jones Elaine VBuy38.00K$2.82107.16K
2025-06-11Gilbert Halley EBuy38.00K$2.82107.16K
2025-06-11Ashworth AlanBuy38.00K$2.82107.16K
2025-03-18McCarthy Sean A.Sell37.66K$0.6022.56K
2025-03-18Ogden ChristopherSell8.55K$0.605.12K
2025-03-18Chu Yu-WayeSell4.03K$0.602.41K
2025-03-18ROWLAND LLOYD ASell10.20K$0.606.11K
2025-03-18BELVIN MARCIASell19.51K$0.6011.69K
2025-02-04BELVIN MARCIABuy57.50K——
2025-02-04BELVIN MARCIABuy35.00K——
2025-02-04BELVIN MARCIABuy150.00K$0.86129.60K
2025-02-04BELVIN MARCIABuy57.50K——
2025-02-04BELVIN MARCIABuy30.00K——
2025-02-04BELVIN MARCIABuy140.00K$0.86120.96K
2025-02-04BELVIN MARCIABuy115.00K$0.8699.36K
2025-02-04Chu Yu-WayeBuy238.00K$0.86205.63K
2025-02-04Chu Yu-WayeBuy57.50K——
2025-02-04Chu Yu-WayeBuy115.00K$0.8699.36K
2025-02-04Chu Yu-WayeBuy56.00K——
2025-02-04Ogden ChristopherBuy225.00K$0.86194.40K
2025-02-04Ogden ChristopherBuy57.50K——
2025-02-04Ogden ChristopherBuy44.00K——
2025-02-04Ogden ChristopherBuy115.00K$0.8699.36K
2025-02-04McCarthy Sean A.Buy195.00K——
2025-02-04McCarthy Sean A.Buy180.00K——
2025-02-04McCarthy Sean A.Buy800.00K$0.86691.20K
2025-02-04McCarthy Sean A.Buy390.00K$0.86336.96K
2024-08-20Landau Jeffrey BBuy11.25K——
2024-08-20Landau Jeffrey BSell4.18K$1.235.14K
2024-08-20Landau Jeffrey BSell11.25K——
2024-08-20BELVIN MARCIABuy11.25K——
2024-08-20BELVIN MARCIASell4.18K$1.235.14K
2024-08-20BELVIN MARCIASell11.25K——
2024-08-20ROWLAND LLOYD ABuy11.25K——
2024-08-20ROWLAND LLOYD ASell4.18K$1.235.14K
2024-08-20ROWLAND LLOYD ASell11.25K——
2024-08-20Ogden ChristopherBuy6.88K——
2024-08-20Ogden ChristopherSell1.98K$1.232.44K
2024-08-20Ogden ChristopherSell6.88K——
2024-08-20McCarthy Sean A.Buy37.50K——
2024-08-20McCarthy Sean A.Sell13.90K$1.2317.08K
2024-08-20McCarthy Sean A.Sell37.50K——
2024-06-12Ogden ChristopherBuy17.50K——
2024-06-12Ogden ChristopherBuy75.00K$1.49111.75K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 189, holders -2 vs prior quarter. Ownership 97.56%.

HolderSharesChangeChange %Value
FMR LLC32.71M759.30K+2.38%122.68M
KYNAM CAPITAL MANAGEMENT, LP21.70M6.69M+44.56%81.39M
BLACKROCK, INC.17.56M12.33M+235.86%65.85M
BANK OF AMERICA CORP /DE/15.08M4.88M+47.83%56.56M
STATE STREET CORP11.75M6.08M+107.42%44.05M
PERCEPTIVE ADVISORS LLC10.44M340.36K+3.37%39.15M
VANGUARD CAPITAL MANAGEMENT LLC8.53M-207.66K-2.38%31.97M
POINT72 ASSET MANAGEMENT, L.P.7.81M-64.36K-0.82%29.29M
WELLINGTON MANAGEMENT GROUP LLP5.17M1.59M+44.26%19.38M
VENROCK ADVISER, LLC4.98M-5.00M-50.09%18.68M
BAKER BROS. ADVISORS LP4.98M00.00%18.66M
GEODE CAPITAL MANAGEMENT, LLC4.68M2.61M+126.40%17.55M
ELMIND CAPITAL, LP4.55M00.00%17.06M
NEXTECH INVEST LTD.4.45M00.00%16.69M
TWO SIGMA INVESTMENTS, LP4.13M1.42M+52.49%15.50M
EVERSEPT PARTNERS, LP3.56M369.98K+11.60%13.34M
UBS GROUP AG3.47M348.20K+11.16%13.01M
SIREN, L.L.C.3.46M00.00%12.97M
ADAR1 CAPITAL MANAGEMENT, LLC3.37M-45.07K-1.32%12.62M
CITADEL ADVISORS LLC3.11M2.97M+2177.09%11.66M
MARSHALL WACE, LLP3.02M-1.11M-26.92%11.34M
WOODLINE PARTNERS LP2.04M39.38K+1.97%7.65M
GOLDMAN SACHS GROUP INC2.00M543.81K+37.25%7.51M
DIMENSIONAL FUND ADVISORS LP1.86M-70.63K-3.66%6.98M
QUBE RESEARCH & TECHNOLOGIES LTD1.82M-425.02K-18.89%6.84M

Earnings and financials

CytomX Therapeutics, Inc. (CTMX) trades at $2.37, with a market cap of $515.33M and a trailing P/E of -5.42. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
1504300071623000595020005748900068427000373120005316300010121400013810300076201000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

CytomX Therapeutics (CTMX) Financials: Revenue & Earnings

CTMX$2.37+0.06 +2.38%

$515.33M

Market Cap

-5.42

P/E

67.57

Forward P/E

46

Score

Price History